Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Schwab US Large Cap Growth ETF (SCHG) vs Tilray Brands Inc (TLRY) Price & Performance

Schwab US Large Cap Growth ETFTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Schwab US Large Cap Growth ETF vs Tilray Brands Inc — how do they compare? Schwab US Large Cap Growth ETF trades at $36.63 (market cap $65.01B), while Tilray Brands Inc trades at $3.43 (market cap $530.54M). The key difference: Schwab US Large Cap Growth ETF is far larger — about 122.5× Tilray Brands Inc's market cap, and Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Schwab US Large Cap Growth ETF for 50 Days and Tilray Brands Inc for 31 Days on average.

SCHGTLRY
Market Cap
$65.01B$530.54M
Volume
8,554,3999,099,075
Sector
Sector/ThematicHealth
52-Week High
$36.93$21.00
52-Week Low
$28.10$3.57
Typical Hold Time
50 Days31 Days
Enterprise Value
—$684.46M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Schwab US Large Cap Growth ETF

SCHG (Schwab U.S. Large-Cap Growth ETF) trades at $36.60, down 0.73% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF maintains strong institutional interest despite a recent position reduction by Corient Private Wealth. Recent news highlights SCHG's low-cost advantage and growth-focused strategy, though concentration in top holdings presents both opportunity and risk.

The outlook for SCHG remains positive given its exposure to large-cap growth stocks and cost efficiency, though investors should monitor concentration risks in top holdings and broader market volatility. The ETF's historical performance suggests potential for long-term growth, but current valuation levels warrant careful assessment relative to alternatives like GARP strategies.

Tilray Brands Inc

TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.

TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SCHG
100% Buy0% Sell
Avg holding period · 50 Days
TLRY
100% Buy0% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Schwab US Large Cap Growth ETF

SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.

Read more on SCHG →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →